Boston Scientific Corp

NYSE: BSX
$87.58
-$1.19 (-1.3%)
Closing Price on November 14, 2024

BSX Articles

24/7 has compiled many of the predictions from various firms and various market pundits for what lies ahead in 2012.  Wall St. modified analyst consensus price target methodology generates 12%...
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Friday morning. AGCO Corporation (NYSE: AGCO) Maintained...
Many research firms have been coming up with their best ideas lists for 2012.  Today brought a list of top picks in the medical technology and medical devices sector from Zacks Investment...
Stock markets. Equity markets opened sharply higher this morning before falling into negative territory before the ISM and factory order reports were released. The ISM index came in lower than...
These are some of Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Annaly Capital Management, Inc. (NYSE: NLY) Raised to Outperform at Wells...
Short sellers moved out of stocks that have fallen recently. Perhaps they believe there will be a large rally in the market. There is little else to make the shares of companies with poor earnings...
Medical device maker Boston Scientific Corp. (NYSE: BSX) has named a new president who will take over on October 17th and who will then be elevated to CEO on November 1, 2012. Was Boston...
Moody’s cuts ratings of France’s Credit Agricole and Societe Generale as Greek debt trouble spreads. (Reuters) Federal Reserve may try to help the economy with more bond purchases. (Reuters)...
Each morning we review our top upgrades, downgrades, and initiations from Wall Street analysts.  At the end of the week, we review these more closely along with other calls made throughout the week...
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Boston Scientific Corporation (NYSE: BSX) Reiterated Buy as Value...
Each morning of the week we pull the top analyst upgrades, downgrades, and initiations from Wall Street research reports.  It turns out that some research calls were far more important or far more...
It is no secret that the market volatility has many investors rattled.  What is very counter-intuitive is that many companies are continuing with most or all of their investor friendly plans...
Financial markets have been reeling as investors grow more concerned about the economy: An S&P downgrade of the full faith and credit of the United States, dismal GDP data, and ongoing weak...
Implanted medical devices are one of the most profitable businesses of the U.S. healthcare industry. While many devices help extend and improve quality of life, a great many others may not be...
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday morning. Alcatel-Lucent (NYSE: ALU) Maintained Underperform but raised...